CTXR
CTXR
NASDAQ · Pharmaceuticals

Citius Pharmaceuticals Inc

$0.54
-0.01 (-2.63%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +617.6% upside
Low Target $3.27
Average Target $3.85
High Target $6.37
Current Price $0.54
Current
$0.54
Target
$3.85
$3.27 $3.85 avg $6.37
Scenario Analysis
Bear Case
$3.27
509.5%
Low target
Base Case
$3.85
+617.6%
Avg target
Bull Case
$6.37
+1,087.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.67
-67.9% from high
52-Week Low
$0.37
+45.0% from low
Target vs 52W High
$3.85
+130.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.8%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +9.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.3%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.7%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +177.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +163.0%